Cargando…

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study

BACKGROUND: Studies have found different waning rates of neutralising antibodies compared with binding antibodies against SARS-CoV-2. The impact of neutralising antibody waning rate at the individual patient level on the longevity of immunity remains unknown. We aimed to investigate the peak levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chia, Wan Ni, Zhu, Feng, Ong, Sean Wei Xiang, Young, Barnaby Edward, Fong, Siew-Wai, Le Bert, Nina, Tan, Chee Wah, Tiu, Charles, Zhang, Jinyan, Tan, Seow Yen, Pada, Surinder, Chan, Yi-Hao, Tham, Christine Y L, Kunasegaran, Kamini, Chen, Mark I-C, Low, Jenny G H, Leo, Yee-Sin, Renia, Laurent, Bertoletti, Antonio, Ng, Lisa F P, Lye, David Chien, Wang, Lin-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987301/ https://www.ncbi.nlm.nih.gov/pubmed/33778792 http://dx.doi.org/10.1016/S2666-5247(21)00025-2

Ejemplares similares

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
por: Tan, Anthony T., et al.
Publicado: (2021)

Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
por: Poh, Chek Meng, et al.
Publicado: (2020)

Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5
por: Tan, Chee-Wah, et al.
Publicado: (2022)

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2021)

Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecoviruses
por: Wang, Lin-Fa, et al.
Publicado: (2022)

Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections
por: Goh, Yun Shan, et al.
Publicado: (2022)

Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
por: Chan, Yi-Hao, et al.
Publicado: (2021)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
por: Ong, Sean Wei Xiang, et al.
Publicado: (2020)

Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell–treated patients
por: Oh, Bernice Ling Zhi, et al.
Publicado: (2022)

Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2
por: Su, Yvonne C. F., et al.
Publicado: (2020)

Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
por: Young, Barnaby E, et al.
Publicado: (2021)

Serological differentiation between COVID-19 and SARS infections
por: Chia, Wan Ni, et al.
Publicado: (2020)

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
por: Renia, Laurent, et al.
Publicado: (2022)

Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccinees and breakthrough infected individuals
por: Tan, Chee Wah, et al.
Publicado: (2023)

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
por: Le Bert, Nina, et al.
Publicado: (2021)

Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
por: Anderson, Danielle E., et al.
Publicado: (2020)

Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young men: Heterogenous immunity to SARS-CoV-2
por: Le Bert, Nina, et al.
Publicado: (2021)

Immunogenicity of COVID-19 vaccines and levels of SARS-CoV-2 neutralising antibody in the Bruneian population: Protocol for a national longitudinal study
por: Ghani, Hazim, et al.
Publicado: (2022)

Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
por: Goh, Yun Shan, et al.
Publicado: (2021)

Neutralising antibody titers and COVID outcomes in cancer patients
por: Lee, Matilda Xinwei, et al.
Publicado: (2023)

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
por: Young, Barnaby E, et al.
Publicado: (2020)

Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors
por: Tan, Chee-Wah, et al.
Publicado: (2021)

Neutralisation and the brickwall
por: Hereward, H G
Publicado: (1974)

Virus Neutralisation: New Insights from Kinetic Neutralisation Curves
por: Magnus, Carsten
Publicado: (2013)

Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
por: Chioh, Florence WJ, et al.
Publicado: (2021)

Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2
por: Chan, Yi‐Hao, et al.
Publicado: (2021)

Myeloperoxidase inhibition may protect against endothelial glycocalyx shedding induced by COVID-19 plasma
por: Teo, Andrew, et al.
Publicado: (2023)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
por: Goh, Yun Shan, et al.
Publicado: (2022)

Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
por: Wang, Bei, et al.
Publicado: (2021)

A prospective observational study of the prevalence and risk factors for colonization by antibiotic resistant bacteria in patients at admission to hospital in Singapore
por: Young, Barnaby E, et al.
Publicado: (2014)

Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection
por: Tay, Matthew Zirui, et al.
Publicado: (2022)

Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19
por: Ng, Deborah H L, et al.
Publicado: (2020)

Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals
por: Lim, Jackwee, et al.
Publicado: (2021)

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study
por: Yung, Chee Fu, et al.
Publicado: (2023)

Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection
por: Lee, Pei Hua, et al.
Publicado: (2020)

Transcriptome analysis of the hormone-sensing cells in mammary epithelial reveals dynamic changes in early pregnancy
por: De Silva, Duvini, et al.
Publicado: (2015)

Clinical features and predictors of severity in COVID-19 patients with critical illness in Singapore
por: Puah, Ser Hon, et al.
Publicado: (2021)

Differential heterologous neutralisation profile against strains within DENV-3 genotype II
por: Tan, K.K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jbbsumuu89g9u2cknp056q65n2